Literature DB >> 16321529

Naphthofuroquinone derivatives: inhibition of receptor tyrosine kinases.

Kee-In Lee1, Youmie Park, Su-Jin Park, Jung-Hwan Hwang, Sung-Jin Lee, Gun-Do Kim, Woo-Kyu Park, Sunghou Lee, Daeyoung Jeong, Jae-Yang Kong, Hee-Kyoung Kang, Heeyeong Cho.   

Abstract

A series of dinaphtho[1,2-b;2',3'-d]furan-7,12-dione derivatives were synthesized and evaluated for inhibitory activities against receptor tyrosine kinases. The naphthofuroquinone compounds with dialkylaminoethoxy group at C(5)-position (7, 8, 10, and 11) manifested strong inhibitory activities against epidermal growth factor receptor and vascular endothelial growth factor receptor. Docking study of 11 with EGFR was also performed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16321529     DOI: 10.1016/j.bmcl.2005.08.115

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Is furazolidone therapy for Helicobacter pylori effective and safe?

Authors:  Vincenzo De Francesco; Enzo Ierardi; Cesare Hassan; Angelo Zullo
Journal:  Dig Dis Sci       Date:  2009-02-20       Impact factor: 3.199

2.  Synthesis of benzonaphthofuroquinones and benzoylnaphthindolizinediones by reactions of flavonoids with dichlone under basylous, oxygenous and aqueous conditions: their cytotoxic and apoptotic activities.

Authors:  Peng Luo; Wanxing Wei; Saqlain Haider; Shabana I Khan; Mei Wang; Weigao Pan; Amar G Chittiboyina
Journal:  RSC Adv       Date:  2020-08-04       Impact factor: 4.036

3.  Design of Anti-infectious Agents from Lawsone in a Three-Component Reaction with Aldehydes and Isocyanides.

Authors:  Christina L Koumpoura; Michel Nguyen; Christian Bijani; Laure Vendier; Elena G Salina; Silvia Buroni; Giulia Degiacomi; Sandrine Cojean; Philippe M Loiseau; Françoise Benoit-Vical; Alfonso T García-Sosa; Michel Baltas
Journal:  ACS Omega       Date:  2022-10-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.